InterK Peptide Therapeutics is a preclinical virtual biotechnology company developing peptide-based immunotherapeutics to treat a range of conditions such as cancer and chronic infections that require immune boosting.
Early stage development of peptide based therapeutic candidates in Sydney Australia
